Traduction de «Bladder cell » (Anglais → Français) :

TERMINOLOGIE

bladder tank [ bladder-type fuel cell | bladder cell | bladder cell tank | bag tank | flexible tank | bladder-type tank ]
réservoir souple [ réservoir souple de carburant | vessie ]

air bladder [ air-bladder | swim bladder | swim-bladder | fish maw | fish-maw | gas bladder ]
vessie gazeuse [ vessie natatoire ]

fuel cell bladder tank
réservoir de carburant souple

bladder-type cell
cellule en caoutchouc souple

A rare neuroendocrine neoplasm arising from neural crest-derived paraganglion cells (most often in the para-aortic region at the level of renal hilii, organ of Zuckerkandl, thoracic paraspinal region, bladder and carotid body) not associated with cat
paragangliome non sécrétant

calculus of the urinary bladder | urinary bladder stone | vesical calculus | cystolith | bladder stone
calcul de la vessie | calcul vésical | cystolithe

overactive bladder [ hyperactive bladder | overactive bladder syndrome ]
vessie hyperactive

hyperactive bladder | overactive bladder | hyper-reflexive bladder
vessie hyperactive

atonic bladder | atony of urinary bladder | flaccid bladder
atonie vésicale

automatic bladder | reflex bladder | spastic bladder
vessie spinale

TRADUCTIONS EN CONTEXTE

There was a Globe and Mail article yesterday about adult stem cells being used to recreate sphincter muscles in the bladder, and about being able to isolate adult stem cells from the same human being and create cardiac tissue in myocardial infarct.
Dans le Globe and Mail d'hier, on parlait de la possibilité d'utiliser des cellules souches adultes pour recréer les muscles sphincters de la vessie, et de pouvoir isoler les cellules souches adultes de la même personne pour créer du tissu cardiaque dans le cas d'un infarctus du myocarde.

We have a Canadian-developed proprietary technology that we call mycobacterial cell wall-DNA complex MCC with which we are now planning a final pivotal phase three clinical trial in patients with superficial bladder cancer.
Nous disposons d'une technique brevetée conçue au Canada que nous appelons le complexe ADN-paroi cellulaire d'origine mycobactérienne (MCC) dont nous prévoyons actuellement la troisième et dernière phase. Il s'agit d'essais cliniques clés sur des patients atteints de cancer superficiel de la vessie.